<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8508183</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1289</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr. Neurol.</journal-id>
<journal-title-group>
<journal-title>Pediatric neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0887-8994</issn>
<issn pub-type="epub">1873-5150</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31005478</article-id>
<article-id pub-id-type="pmc">6837240</article-id>
<article-id pub-id-type="doi">10.1016/j.pediatrneurol.2019.03.003</article-id>
<article-id pub-id-type="manuscript">NIHMS1045432</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Tuberous Sclerosis Complex Genotypes and Developmental Phenotype</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Farach</surname>
<given-names>Laura S.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pearson</surname>
<given-names>Deborah A.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Woodhouse</surname>
<given-names>John P.</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schraw</surname>
<given-names>Jeremy M.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sahin</surname>
<given-names>Mustafa</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Krueger</surname>
<given-names>Darcy A.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A6">f</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Joyce Y.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A7">g</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bebin</surname>
<given-names>Elizabeth M.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A8">h</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lupo</surname>
<given-names>Philip J.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A3">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Au</surname>
<given-names>Kit Sing</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Northrup</surname>
<given-names>Hope</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">a</xref>
</contrib>
<on-behalf-of>TACERN Study Group</on-behalf-of>
</contrib-group>
<aff id="A1"><label>a</label>Department of Pediatrics, Division of Medical Genetics, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas</aff>
<aff id="A2"><label>b</label>Department of Psychiatry, Division of Child and Adolescent Psychiatry, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas</aff>
<aff id="A3"><label>c</label>Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, Texas</aff>
<aff id="A4"><label>d</label>Department of Medicine, Section of Epidemiology and Population Sciences, Baylor College of Medicine, Houston, Texas</aff>
<aff id="A5"><label>e</label>Translational Neuroscience Center, Department of Neurology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts</aff>
<aff id="A6"><label>f</label>Division of Neurology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio</aff>
<aff id="A7"><label>g</label>Division of Pediatric Neurology, UCLA Mattel Children’s Hospital and David Geffen School of Medicine, Los Angeles, California</aff>
<aff id="A8"><label>h</label>University of Alabama at Birmingham, Birmingham, Alabama</aff>
<author-notes>
<corresp id="CR1"><label>*</label>Communications should he addressed to: Laura S. Farach; 6431 Fannin Street MSB 3.142; Houston, TX 77030., <email>Laura.S.Farach@uth.tmc.cdu</email> (L.S. Farach).</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>13</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>13</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>7</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>07</day>
<month>11</month>
<year>2019</year>
</pub-date>
<volume>96</volume>
<fpage>58</fpage>
<lpage>63</lpage>
<!--elocation-id from pubmed: 10.1016/j.pediatrneurol.2019.03.003-->
<abstract id="ABS1">
<sec id="S1">
<title>Background:</title>
<p id="P1">Children with tuberous sclerosis complex (TSC), caused by pathogenic variants in <italic>TSC1/TSC2</italic>, are at risk for intellectual disability. <italic>TSC2</italic> pathogenic variants appear to increase the risk, compared with <italic>TSC1</italic>. However, the effect of <italic>TSC2</italic> pathogenic variants on early and specific domains of development hasn’t been studied. Using an extensively phenotyped group, we aimed to characterize differences in early intellectual development between genotypes.</p>
</sec>
<sec id="S2">
<title>Methods:</title>
<p id="P2">The study group (n = 92) included participants with TSC enrolled in a multicenter study involving genetic testing and detailed prospective phenotyping including the Mullen Scales of Early Learning, a validated measure of cognition, language, and motor development in babies and preschool children. Mean T-scores at 24 months for each Mullen Scales of Early Learning domain were calculated for children with, versus without, a <italic>TSC2</italic> pathogenic variant. Multivariable linear regression models were used to compare the groups, adjusting for seizures.</p>
</sec>
<sec id="S3">
<title>Results:</title>
<p id="P3">T-scores on every Mullen Scales of Early Learning domain were significantly worse in the <italic>TSC2</italic> group. Below average composite scores were present in three-fourths of the <italic>TSC2</italic> group, compared with one-fourth of those without <italic>TSC2</italic>. Having a <italic>TSC2</italic> pathogenic variant was associated with lower composite Mullen Scales of Early Learning scores, even when corrected for seizures.</p>
</sec>
<sec id="S4">
<title>Conclusions:</title>
<p id="P4">In a well-characterized patient population with standardized assessment of multiple aspects of development, we found that having a <italic>TSC2</italic> pathogenic variant was associated with significantly lower Mullen Scales of Early Learning scores at age 24 months, independent of seizures. These data suggest that a baby with a <italic>TSC2</italic> pathogenic variant is at high risk for significant developmental delays by 24 months.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Tuberous sclerosis complex (TSC)</kwd>
<kwd>Genotype</kwd>
<kwd>Phenotype</kwd>
<kwd>Developmental delay</kwd>
<kwd>Mullen scales of early learning (MSEL)</kwd>
<kwd>Genotype-phenotype correlation</kwd>
<kwd>Cognition</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>